doi:10.1016/j.ophtha.2025.01.016 37
Unlike whole-cell therapies, MSC-Exos mitigate risks associated with tumor formation and immune rejection while maintaining the regenerative and anti-inflammatory properties of their parent cells [10]
What works well for one person may look different for another, and success often depends on more than just medicationits about the full picture
Store the reconstituted solution at 28C and use within 28 days
In terms of halflife (T1/2), DPP4 inhibitors differ: saxagliptin (including its active metabolite) and vildagliptin have short halflives, sitagliptin and alogliptin have moderately long halflives, teneligliptin has a long halflife, while linagliptin has a terminal halflife of over 100 h due to its nonlinear pharmacokinetic profile, which arises from its highaffinity binding to the DPP4 enzyme, its main target [91] but an effective halflife of approximately 12 h (Table 1)
Liposomal Delivery Liposomal delivery is designed to provide the benefits of an IV in a convenient liquid format
